Blue Jet Healthcare Limited has announced the successful closure of its Qualified Institutions Placement (QIP) of equity shares.
The company issued 1,58,10,276 equity shares at an issue price of ₹506 per share, raising a total of ₹800 crore. The QIP opened on July 6, 2026, and closed on July 9, 2026, as per the exchange filings.
The QIP involved the issuance of 1,58,10,276 equity shares, each with a face value of ₹2. The shares were priced at ₹506, including a premium of ₹504 per share.
The final price included a discount of ₹25.70, which is 4.83% below the initial floor price. The total funds raised amounted to ₹8,000 million.
Prior to the QIP, Blue Jet Healthcare's paid-up share capital was ₹34,69,30,850, consisting of 17,34,65,425 shares. Following the QIP, the paid-up share capital increased to ₹37,85,51,402, comprising 18,92,75,701 shares.
2 major institutional investors received significant allocations in the QIP. Shamyak Investment Private Limited (SI NBFC) was allotted 54,34,785 shares, representing 34.38% of the total issue size.
ICICI Prudential Mutual Funds received an aggregate of 53,35,974 shares, spread across 7 distinct schemes, accounting for 33.75% of the issue size.
Read More: Havells Partners with Norway's Pixii to Enter India's Battery Energy Storage Market!
As of July 10, 2026, at 10:24 AM, Blue Jet Healthcare share price on NSE was trading at ₹615.30, up by 7.10% from the previous closing price.
Blue Jet Healthcare's QIP resulted in the issuance of 1,58,10,276 equity shares at ₹506 each, raising ₹800 crore. The paid-up share capital increased from ₹34,69,30,850 to ₹37,85,51,402. Major allottees included Shamyak Investment and ICICI Prudential Mutual Funds.
Read stock market news in Hindi. Head to Angel One's share market news in Hindi for comprehensive coverage.
Disclaimer: This blog has been written exclusively for educational purposes. The securities or companies mentioned are only examples and not recommendations. This does not constitute a personal recommendation or investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.
Investments in the securities market are subject to market risks, read all the related documents carefully before investing.
Published on: Jul 10, 2026, 10:53 AM IST
Team Angel One
We're Live on WhatsApp! Join our channel for market insights & updates
Get the link to download the App
